新华制药,000756,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 解热镇痛类等原,139204,90905,48299,34.7%,49.63% 片剂、针剂、胶囊剂等制剂,140418,95831,44587,31.75%,45.81% 医药中间体及其他,30367,25934,4434,14.6%,4.56% 新华制药,000756,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药中间体及其他,67537,-- ,-- ,--,--% 片剂、针剂、胶囊剂等制剂,221308,-- ,-- ,--,--% 解热镇痛类等原料药,231942,-- ,-- ,--,--% 新华制药,000756,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 片剂、针剂、胶囊剂等制剂,118263,78294,39969,33.8%,53.38% 医药中间体及其他,33147,30381,2766,8.34%,3.69% 解热镇痛类等原料药,117358,85221,32137,27.38%,42.92% 新华制药,000756,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 解热镇痛类等原料药,196452,139662,56790,28.91%,44.78% 片剂、针剂、胶囊剂等制剂,198219,138181,60038,30.29%,47.34% 医药中间体及其他,56901,46919,9982,17.54%,7.87% 新华制药,000756,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 解热镇痛类原料药,61489,48410,13079,21.27%,19.81% 其他产品,178838,125912,52926,29.59%,80.19% 新华制药,000756,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他产品,236716,-- ,-- ,--,--% 复方甘草片,4130,-- ,-- ,--,--% 库欣,8031,-- ,-- ,--,--% 雷贝拉唑钠肠溶片,7441,-- ,-- ,--,--% 异丙基安替比林,2556,-- ,-- ,--,--% 氨基比林,9107,-- ,-- ,--,--% 阿司匹林,15133,-- ,-- ,--,--% 左旋多巴,18567,-- ,-- ,--,--% 咖啡因,32601,-- ,-- ,--,--% 安乃近,29828,-- ,-- ,--,--% 布洛芬,37386,-- ,-- ,--,--% 新华制药,000756,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1711,2514,-802,-46.89%,-1.75% 其他产品,177808,134904,42904,24.13%,93.72% 布洛芬,20331,16653,3678,18.09%,8.03% 新华制药,000756,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药中间体及其他,46040,39504,6536,14.2%,7.81% 制剂,165877,122908,42970,25.9%,51.36% 化学原料药,147786,113627,34159,23.11%,40.83% 新华制药,000756,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其中:原料药出口,54773,48161,6611,12.07%,13.64% 化工及其他,14916,12307,2609,17.49%,5.38% 原料药,80212,64211,16001,19.95%,33.01% 商业流通,48194,45984,2211,4.59%,4.56% 其他(补充),2632,2823,-191,-7.25%,-0.39% 制剂,48887,27662,21224,43.42%,43.79% 新华制药,000756,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其中:原料药出口,107595,92325,15270,14.19%,17.2% 化工及其他,32589,27891,4698,14.42%,5.29% 原料药,152284,124461,27823,18.27%,31.35% 商业流通,82370,78592,3779,4.59%,4.26% 其他(补充),3596,4458,-862,-23.98%,-0.97% 制剂,88136,50092,38044,43.17%,42.87% 新华制药,000756,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1587,2148,-561,-35.38%,-1.38% 化工及其他,16014,13338,2677,16.71%,6.59% 商业流通,38601,36548,2053,5.32%,5.06% 制剂,35359,21991,13368,37.81%,32.92% 其中:原料药出口,57756,48824,8932,15.47%,22% 原料药,82120,67986,14135,17.21%,34.81% 新华制药,000756,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),3321,3726,-405,-12.2%,-0.63% 商业流通,81453,77451,4002,4.91%,6.26% 化工及其他,24052,23847,205,0.85%,0.32% 制剂,55201,33306,21895,39.66%,34.25% 其中:原料药出口,108262,95678,12584,11.62%,19.69% 原料药,152938,127299,25639,16.76%,40.11% 新华制药,000756,收入构成,报告日期,2013-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1713,1967,-254,-14.8%,-0.79% 化工及其他,10394,11353,-959,-9.23%,-2.99% 商业流通,41150,39209,1941,4.72%,6.05% 制剂,30347,18095,12252,40.37%,38.2% 其中:原料药出口,56023,49288,6735,12.02%,21% 原料药,78109,65749,12360,15.82%,38.53% 新华制药,000756,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),3940,4288,-347,-8.81%,-0.51% 商业流通,71884,69704,2180,3.03%,3.22% 化工及其他,20452,22112,-1660,-8.12%,-2.45% 制剂,59730,35546,24184,40.49%,35.74% 其中:原料药出口,102844,87602,15242,14.82%,22.52% 原料药,141147,113071,28076,19.89%,41.49% 新华制药,000756,收入构成,报告日期,2012-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其他,9533,10262,-728,-7.64%,-2.06% 其中:原料药出口,55787,47851,7936,14.23%,22.47% 其他(补充),2119,2460,-342,-16.12%,-0.97% 商业流通,38587,37217,1370,3.55%,3.88% 制剂,29064,16178,12886,44.34%,36.49% 原料药,74490,60300,14190,19.05%,40.18% 新华制药,000756,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),3411,4048,-637,-18.69%,-0.89% 化工及其他,13851,11894,1958,14.13%,2.75% 商业流通,73436,69740,3697,5.03%,5.18% 制剂,55031,33826,21205,38.53%,29.74% 其中:原料药出口,106635,89927,16708,15.67%,23.43% 原料药,148024,119651,28373,19.17%,39.79% 新华制药,000756,收入构成,报告日期,2011-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其他,6737,5574,1163,17.27%,4.31% 商业流通,35869,34208,1660,4.63%,6.15% 制剂,27036,16784,10252,37.92%,37.99% 原料药,80514,66602,13912,17.28%,51.55% 新华制药,000756,收入构成,报告日期,2010-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工及其他,8026,6711,1315,16.38%,2.69% 商业流通,68431,64600,3831,5.6%,7.85% 制剂,51063,36041,15022,29.42%,30.78% 原料药出口,129782,101138,28643,22.07%,58.68% 新华制药,000756,收入构成,报告日期,2010-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工及其他,2777,1945,832,29.95%,3.29% 商业流通,32931,31212,1719,5.22%,6.8% 制剂,25513,18057,7456,29.22%,29.52% 原料药,73219,57964,15255,20.83%,60.39% 新华制药,000756,收入构成,报告日期,2009-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工及其他,397,291,106,26.76%,0.24% 商业流通,59906,58561,1345,2.25%,2.99% 制剂,47281,33626,13655,28.88%,30.31% 原料药,120847,90904,29943,24.78%,66.47% 新华制药,000756,收入构成,报告日期,2009-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其他,190,130,60,31.65%,0.27% 商业流通,31438,30695,743,2.36%,3.34% 制剂,24464,17912,6551,26.78%,29.43% 原料药,61407,46498,14909,24.28%,66.97% 新华制药,000756,收入构成,报告日期,2008-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工及其他,1885,1826,59,3.1%,0.2% 商业流通,41289,39414,1876,4.54%,6.4% 制剂,40429,29513,10916,27%,37.23% 原料药,122271,105801,16471,13.47%,56.17% 新华制药,000756,收入构成,报告日期,2008-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其他,579,318,261,45.05%,1.66% 商业流通,23191,22481,711,3.06%,4.51% 制剂,20377,14574,5803,28.48%,36.8% 原料药,67767,58775,8992,13.27%,57.03% 新华制药,000756,收入构成,报告日期,2007-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工及其他,884,438,446,50.44%,2.08% 商业流通,33280,30897,2382,7.16%,11.1% 制剂,34035,26224,7811,22.95%,36.39% 原料药出口,85210,74384,10826,12.7%,50.43% 新华制药,000756,收入构成,报告日期,2007-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其他,182,96,86,47.37%,0.54% 商业流通,17260,16749,510,2.96%,3.18% 制剂,16690,12307,4384,26.26%,27.34% 原料药,59524,48469,11055,18.57%,68.94% 新华制药,000756,收入构成,报告日期,2006-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其它,1865,1944,-79,-4.23%,-0.27% 商业流通,39962,38997,966,2.42%,3.26% 制剂,27166,18525,8641,31.81%,29.2% 化学原料药,97732,77670,20062,20.53%,67.8% 新华制药,000756,收入构成,报告日期,2006-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其它,1479,1565,-86,-5.83%,-0.39% 其他批发和零售贸易,30239,29648,590,1.95%,2.69% 化学药品制剂,19588,13436,6153,31.41%,28.05% 化学药品原料药,74173,58892,15281,20.6%,69.66% 新华制药,000756,收入构成,报告日期,2006-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他行业,955,968,-13,-1.34%,-0.08% 其他批发和零售贸易,21632,21196,436,2.02%,2.74% 化学药品制剂制造业,13282,8726,4556,34.3%,28.66% 化学药品原药制造业,50294,39378,10916,21.7%,68.67% 新华制药,000756,收入构成,报告日期,2006-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其他,518,482,36,6.98%,0.4% 商业流通,10924,10744,180,1.65%,1.98% 制剂,7342,4609,2733,37.23%,29.95% 化学原料药,27269,21091,6178,22.65%,67.68% 新华制药,000756,收入构成,报告日期,2005-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其他,1609,1775,-166,-10.29%,-0.55% 商业流通,40820,39660,1160,2.84%,3.84% 制剂,29804,18198,11606,38.94%,38.48% 化学原料药,97419,79854,17564,18.03%,58.23% 新华制药,000756,收入构成,报告日期,2005-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其它,758,919,-160,-21.15%,-1.01% 商业流通,19477,19068,409,2.1%,2.58% 制剂,15359,9342,6017,39.18%,37.96% 原料药,51574,41987,9587,18.59%,60.47% 新华制药,000756,收入构成,报告日期,2005-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其他,409,522,-113,-27.58%,-1.39% 商业流通,8734,8523,211,2.41%,2.59% 制剂,9176,5941,3235,35.26%,39.73% 化学原料药,26447,21638,4809,18.18%,59.07% 新华制药,000756,收入构成,报告日期,2004-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其他,1643,2150,-506,-30.81%,-2.07% 商业流通,36922,36242,680,1.84%,2.78% 制剂,29608,18472,11137,37.61%,45.52% 化学原料药,82957,69802,13154,15.86%,53.77% 新华制药,000756,收入构成,报告日期,2004-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其他,3174,2979,195,6.15%,1.35% 制剂,27985,21785,6201,22.16%,42.9% 原料药,49054,40996,8058,16.43%,55.75% 新华制药,000756,收入构成,报告日期,2004-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其他,1474,1484,-9,-0.63%,-0.12% 制剂,14419,10963,3457,23.97%,43.52% 化学原料药,23439,18944,4495,19.18%,56.6% 新华制药,000756,收入构成,报告日期,2003-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其他,4128,3491,637,15.43%,2.12% 制剂,50343,36431,13913,27.64%,46.24% 化学原料药,78376,62840,15536,19.82%,51.64% 新华制药,000756,收入构成,报告日期,2003-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品,3196,2751,445,13.94%,2.03% 制剂,37577,27701,9876,26.28%,44.96% 化学原料药,59540,47894,11646,19.56%,53.01% 新华制药,000756,收入构成,报告日期,2003-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其他,1956,1658,298,15.22%,1.79% 制剂,24571,17156,7415,30.18%,44.55% 原料药,41209,32277,8932,21.67%,53.66% 新华制药,000756,收入构成,报告日期,2003-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 安乃近,4711,3296,1416,30.05%,100% 新华制药,000756,收入构成,报告日期,2002-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其他,3201,2258,943,29.45%,2.99% 制剂,39200,26969,12231,31.2%,38.84% 原料药,74955,56636,18319,24.44%,58.17% 新华制药,000756,收入构成,报告日期,2001-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化工产品及其他,2185,1517,668,30.58%,2.01% 制剂,39874,25751,14123,35.42%,42.47% 原料药,67867,49407,18460,27.2%,55.52%